Navigation Links
Hill-Rom Reports Second Quarter Financial Results
Date:5/4/2009

- Revenue of $337 million declined 10.1 percent versus prior year primarily due to economic impact on U.S. hospital capital spending and foreign exchange

- Adjusted earnings per fully diluted share from continuing operations was $0.27 versus $0.26 in prior year, an increase of 3.8 percent

- GAAP loss per fully diluted share from continuing operations of $7.44 resulted from estimated $470 million non-cash intangible impairment charge related to market value decline

- Adjusted operating expenses exclusive of Liko declined $19.8 million (14.2 percent) on initiatives to reduce cost structure

- Liko performance and integration progressing as expected

- Cash flow and liquidity improved versus prior year and sequentially

- Management updates adjusted annual financial guidance for fiscal year 2009 to $0.85 to $1.15 per fully diluted share

BATESVILLE, Ind., May 4 /PRNewswire-FirstCall/ -- Hill-Rom Holdings, Inc. (NYSE: HRC), announced unaudited financial results for its fiscal second quarter ended March 31, 2009. Revenue was $337.3 million, a 10.1 percent decrease from $375.2 million in the prior year comparable period. On a constant currency basis, revenue decreased 5.7 percent. Organic revenue (excludes currency impact and Liko revenue of $18.0 million) decreased 10.5 percent. Hill-Rom incurred a net loss from continuing operations of $465.8 million, or $7.44 per fully diluted share, on an impairment of goodwill and other intangibles of $470 million. Adjusted earnings per fully diluted share from continuing operations were $0.27, an increase of 3.8 percent from the prior year. Adjustments in the current period include the impairment of intangibles, effects of severance and related expenses associated with job eliminations and other actions announced in
'/>"/>

SOURCE Hill-Rom Holdings, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19

Related medicine news :

1. Hill-Rom to Present at the Bank of America 2009 Health Care Conference
2. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 Second Quarter Earnings Webcast
3. JCR and Hill-Rom Name First Nurse Scholar-in-Residence
4. Hill-Rom Announces Second Quarter 2009 Dividend
5. Hill-Rom to Present at the Canaccord Adams Musculoskeletal Conference
6. Hill-Rom Reports First Quarter Revenue Growth of 3.0 Percent to $352 Million and Earnings Per Fully Diluted Share From Continuing Operations of $0.23, an Increase of 15.0 Percent From the Prior Year
7. DRE Medical Equipment Now Sells Reconditioned Hill-Rom Hospital Beds
8. Hill-Rom Holdings, Inc. Invites You to Join Its Fiscal 2009 First Quarter Earnings Webcast
9. Hill-Rom Reports First Quarter Revenue of $350 Million and Announces Further Actions to Address Challenging Economic Environment
10. JCR, Hill-Rom Launch Nurse Safety Scholar-in-Residence Program
11. Hill-Rom Announces First Quarter 2009 Dividend

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/7/2009)...A. Cook (GA), Louis J. Goodman (TX), Palmer P. Jon...GO, Nov. 7 The American...dical society executive leaders with achievement a...d ideals of the medical profession. The awards wer... meeting in Houston. ,, (Logo: http://www.ne...
(Date:11/7/2009)...a responsibility to vigorously oppose abortion in ... WASHINGTON, Nov. 7 ...d the following statement on the news that Cardina...s Affordable Health Care for America Act (H.R. 396...o for abortion is voted upon. ,, "Our Catholic...
(Date:11/7/2009)...Society of America (PRSA) will bestow the distingu...r vice president of Brand Strategy, Communications...ny at PRSA,s 2009 International Conference in San ...of Fellows is one of the profession,s highest indi...llow PRSA, and 2009 chair of the College of Fellow...
(Date:11/7/2009)...economic climate, many Americans are monitoring th...y on what that they consider to be absolutely esse...elieves that it’s very important for overwei...o improve their health, and he is trying to make w...tough economy by offering reasonable prices and mu...
(Date:11/6/2009)...Georgia graduate was featured in a local news show.... The special report focused on the growing proble...rt Andrew shared his near death experience and his...iption drug abuse. ,, "I woke up, blinked once and...er on top of me giving me CPR. I saw tears streami...
Breaking Medicine News(10 mins):Health News:AMA Honors Medical Society Executives 2Health News:Statement Regarding Cardinal Rigali's Memo Protecting the 'Status Quo' On Life 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 2Health News:PRSA Inducts Head of Public Relations for Kaiser Permanente Into the College of Fellows for Contributions to the Profession and Lifetime Achievement 3Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 2Health News:Dallas Bariatric Surgeon Offers Multiple Options for Patients Considering Weight Loss Surgery in a Rough Economy 3Health News:Narconon Drug Rehab of Georgia Graduate Featured on Local News 2
...Researchers in the North Central Cancer Treatment ... intravenous calcium and magnesium before and afte...ent of advanced colon cancer experience a signific...omplete a full course of treatment. The findings ...
...creased use of MRI before surgeries, researchers r... -- After years of declining rates, the number of ... is on the rise again, the Mayo Clinic now reports...sent their findings May 31 at the American Society...
...lif., May 16 Anesiva,Inc. (Nasdaq: ANSV ) today ...hief executive officer, will present at the Citi I... New York City on May 22, 2008 at 9:30 a.m.,EDT., ...lease connect to Anesiva,s website several minutes...
...16 Jazz,Pharmaceuticals, Inc. (Nasdaq: JAZZ ) an...resident, will provide a corporate presentation at...ll speak at the UBS Global Specialty and Generic,P... the FBR Capital,Markets Spring Investor Conferenc...
...d ABT-869 to be Promising in Targeting Cancer Cell... ABBOTT PARK, Ill., May 15 Abbott scientists,will...al investigative,compounds in the company,s oncolo...-263, a Bcl-2 family protein,antagonist, and ABT-8...
...-control audit of community hospitals associated w...ts that a partnership between a major academic can... created, and community hospitals, where most care...mprehensive Cancer Center in Philadelphia, first e...
Other Medicine News:Health News:Study shows that administering calcium and magnesium effectively reduces neurological sensitivity 2Health News:Mastectomies on the Increase 2Health News:Mastectomies on the Increase 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 2Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 3Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 4Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 5Health News:Abbott to Present Data on Novel Cancer Treatments at American Society of Clinical Oncology Annual Meeting 6Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 2Health News:Partnership of academic centers and community hospitals effective model for disseminating advances 3
(Date:11/6/2009)...ire/ -- Kaiser Foundation Health Plan, Inc., Kaise...aries reported today a combined total operating re...mber 30, 2009, compared to $10.2 billion in the th...third quarter was $336 million, compared to $307 m...operating income was $233 million in the third qua...
(Date:11/6/2009)...tCall/ -- Caraco Pharmaceutical Laboratories, Ltd....amine ophthalmic solution, 0.5% following a final ...(FDA) for Sun Pharma,s Abbreviated New Drug Applic...olution on the first day following patent expirati...equivalent to Acular® Ophthalmic Solution, 0....
(Date:11/6/2009)...ire-FirstCall/ -- Derma Sciences, Inc. (OTC Bu...care products, announced plans to release its thir...vember 16, 2009. The Company will hold a conferenc...00 am EST. Interested parties should call (866) 78...), with passcode 81416481 to access the call. You ...
Breaking Medicine Technology:Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 2Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 3Kaiser Foundation Health Plan and Hospitals Report Third Quarter 2009 Financial Results 4Caraco Pharmaceutical Laboratories, Ltd. Markets Generic Acular(R) Ophthalmic Solution 2Derma Sciences Announces Date of Its Third Quarter 2009 Earnings Release and Conference Call 2Contour Products Promotes Survey for National Respiratory Care Week Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 60156 1Contour Products Promotes Survey for National Respiratory Care Week Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 60156 2Contour Products Promotes Survey for National Respiratory Care Week Findings Prove Benefits of Contour CPAP Pillow for Sleep Apnea Patients 60156 3PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 1PrepareCo com Introduces New Online Source for Emergency Self Reliant Food 26amp 3B Survival Products 60151 2TOPAZ Technologies Announces SoBran Inc as New Customer 14612 1TOPAZ Technologies Announces SoBran Inc as New Customer 14612 2TOPAZ Technologies Announces SoBran Inc as New Customer 14612 3
...ICAAC -, BRIDGEWATER, N.J., Sept. 18 Results fro... Phase 3 study showed that 84 percent of,treatment...onal dose of,PREZISTA(TM) (darunavir) 800 mg (two ...ith TRUVADA(R)(1) (emtricitabine and tenofovir dis...ad (<50 copies/mL) at week 48,compared with 78...
...eutics,(Nasdaq: FOLD ) today announced that it pl...T2220 (1-deoxynojirimycin HCl) for Pompe Disease a...nual Meeting on October 23-27,in San Diego, CA. Th...nd,Chief Executive Officer, at the Merrill Lynch G...ence in London, United Kingdom. About Amicus Ther...
Other Medicine Technology:New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 2New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 3New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 4New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 5New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 6New Phase 3 Study in Treatment-Naive Adults with HIV Evaluates Efficacy and Safety of Once-Daily PREZISTA(TM)/ritonavir vs. KALETRA(R) as Part of HIV Combination Therapy 7Amicus Therapeutics Announces Plans to Present Phase 1 Data for AT2220 for Pompe Disease 2
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
...boratories is a national reference laboratory and ...ch and development. ARUP offers an extensive test ... clinical and anatomic pathology. Owned by the Uni...e more than half of the nation's university teachi...
Medicine Products: